Top section
Top section
Investors were eager to tender their bonds despite initial resistance
Banker had been with Dutch lender for just over a year
Data
More articles
More articles
More articles
-
Chinese biopharmaceutical firm 3SBio has taken one step closer to spinning off and listing a unit on Shanghai’s Nasdaq-style Star Market. -
Central China Real Estate priced a $200m four non-call two year bond on Thursday, after surprisingly strong demand allowed it to tighten pricing aggressively.
-
Goldman Sachs’ co-head of China investment banking Hansong Zhu is retiring after 19 years with the bank, according to an internal memo seen by GlobalCapital Asia.
-
Chinese pharmaceuticals firm WuXi Biologics and one of its controlling shareholders are set to raise a combined HK$7.9bn ($1bn) from the sale of equal chunks of shares in the company.
-
In this round-up, the Chinese Communist Party (CCP) said it will strengthen the country’s ideological and institutional design, the Chilean government called off a planned Apec meeting and the State Administration for Market Regulation (SAMR) and the People’s Bank of China released a list of certified fintech products.
-
South Korean defence and information technology firm Hanwha Systems priced its IPO at the bottom of the range on Friday after a poor showing from investors at home and abroad, according to a source close to the deal.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
